Perrigo Company plc Announces Quarterly Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Goldman Sachs to acquire real estate company LCN for up to $410M
S&P Downgrades Perrigo (PRGO) to 'BBB-'; Sees Weakness in High-Margin Business
April 26, 2016 12:14 PM EDTStandard & Poor's Ratings Services lowered all of its ratings on Perrigo Co. plc (NYSE: PRGO), including the corporate credit rating to 'BBB-' from 'BBB'. The outlook is stable. Reported debt outstanding as of Dec. 31, 2015 was about $6 billion.
"The downgrade reflects our expectation for weakness in Perrigo's high-margin generic pharmaceutical business, largely resulting from intensifying competition and lower pricing, and a further expected decline in the recently acquired European branded consumer business," said Standard & Poor's credit analyst Gerald Phelan. "As a result, we now forecast adjusted debt-to-EBITDA in the mid-3x area over... More
